The decrease in CD4, CD25 T cells complemented a higher ratio of the percentage of CD8:CD4, CD25 T cells (p = 0.0074), which correlates with increased anti-tumor activity by CD8 T cells [48]. The gene discussed is CD4; the disease is neoplasm.